Ignite Creation Date:
2024-05-06 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03525145
Status:
UNKNOWN
Last Update Posted:
2019-01-04
First Post:
2018-04-25
Brief Title:
Platelet Reactivity And Clinical ThrombotIC Events Study
Sponsor:
Shenyang Northern Hospital
Organization:
Shenyang Northern Hospital
Study Overview
Official Title:
Platelet Reactivity And Clinical ThrombotIC Events Study
Status:
UNKNOWN
Status Verified Date:
2019-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRACTICE
Brief Summary:
Platelet function testing has been considered for DAPT strategy adjustments to reduce the patients risk of ischemia and bleeding Although several previous RCT studies did not find any benefit in the detection of platelet function the previous studies were mostly low-risk populations and the P2Y12 receptor antagonists were simply clopidogrel and the detection methods were relatively simple Therefore the need for platelet monitoring in high-risk ACS patients receiving new potent P2Y12 inhibitor ticagrelor as well as the diagnostic threshold for different platelet function assays needs further study In addition due to the differences on the response to anti-platelet drugs between the East and the West it is not appropriate to simply refer to the conclusion of the other party However as of now there is no large sample randomized controlled study systematically focused on the applicability and status of platelet function tests in East Asian populations especially Chinese populations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None